✦ LIBER ✦

Indications for surgical treatment of epilepsy in childhood: a clinical and neurophysiological approach

✍ Scribed by L Fusco; F Vigevano

Book ID: 114814180
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 96 KB
Volume: 93
Category: Article
ISSN: 0803-5253
DOI: 10.1111/j.1651-2227.2004.tb03052.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lamotrigine as first-line drug in childh

Lamotrigine as first-line drug in childhood absence epilepsy: a clinical and neurophysiological study

✍ Giangennaro Coppola; Felicia Licciardi; Nicola Sciscio; Francesco Russo; Marco C 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Surgical treatment of severe autistic re

Surgical treatment of severe autistic regression in childhood epilepsy

✍ Brian G.R. Neville; William F.J. Harkness; J.Helen Cross; Hilary C. Cass; Victor 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 422 KB

Surgical Treatment of Intractable Epilep

Surgical Treatment of Intractable Epilepsy in Children: Indication for Resective Surgery

✍ Taisuke Otsuki; Takashi Yoshimoto 📂 Article 📅 2000 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 191 KB

Patient satisfaction with surgical treat

Patient satisfaction with surgical treatment of refractory epilepsy done in childhood and early adolescence

✍ D. L. Keene; Inge Loy-English; Enrique C. G. Ventureyra 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 41 KB

Surgical approach of pulmonary hydatidos

Surgical approach of pulmonary hydatidosis in childhood

✍ I.C. Kurkcuoglu; A. Eroglu; N. Karaoglanoglu; A. Turkyilmaz; C. Tekinbas; A. Bas 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 349 KB

Indications for and benefits of intensiv

Indications for and benefits of intensive therapies in treatment of childhood cancers

✍ Beatrice C. Lampkin; K. Y. Wong 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 771 KB

There has been a striking improvement in the overall numbers of children and adolescents who become disease-free and remain disease-free as a result of intensive therapy as defined today, for the following cancers: acute nonlymphocytic leukemia (ANLL), non-Hodgkin's lymphoma (NHL), poor risk acute l